Lotus pours $200m back into Alvogen to buy Asian businesses
This article was originally published in Scrip
Executive Summary
Alvogen and Lotus Pharmaceuticals have become further entwined after Lotus has agreed to acquire several of Alvogen's businesses in Asia using the money gained from Alvogen's purchase of a 67% stake in Lotus last year.